[1] |
Kahn SR. Measurement of properties of the Villalta scale to define and classify the severity of post-thrombotic syndrome[J].J Thromb Haemost, 2009, 7(5): 884-888.
|
[2] |
Douketis JD, Crowther MA, Foster GA, et al. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?[J]. Am J Med, 2001, 110(7): 515-519.
|
[3] |
Prandoni P, Villalta S, Bagatella P, et al. The clinical course of deep-vein thrombosis: prospective long-term follow-up of528 symptomatic patients[J]. Haematologica, 1997, 82(4): 423-428.
|
[4] |
Haig Y, Enden T, GrøTta O, et al. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial[J]. Lancet Haematol, 2016, 3(2): e64-e71.
|
[5] |
Vedantham S, Goldhaber SZ, Julian JA, et al. ATTRACT trial investigators. pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis[J]. N Engl J Med, 2017, 377(23):2240-2252.
|
[6] |
Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis[J]. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med, 1998, 338(7): 409-415.
|
[7] |
Jia Z, Fuller TA, McKinney JM, et al. Utility of retrievable inferior vena cava filters: a systematic literature review and analysis of the reasons for nonretrieval of filters with temporary indications[J]. Cardiovasc Intervent Radiol, 2018, 41(5): 675-682.
|
[8] |
Sarosiek S, Rybin D, Weinberg J, et al. Association between inferior vena cava filter insertion in trauma patients and in-hospital and overall mortality[J]. JAMA Surg, 2017, 152(1):75-81.
|
[9] |
Hemmila MR, Osborne NH, Henke PK, et al. Prophylactic inferior vena cava filter placement does not result in a survival benefit for trauma patients[J]. Ann Surg, 2015, 262(4): 577-585.
|
[10] |
Mismetti P, Laporte S, Pellerin O, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial[J]. JAMA, 2015, 313(16): 1627-1635.
|
[11] |
Stein PD, Matta F, Keyes DC, et al. Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism[J]. Am J Med, 2012, 125(5): 478-484.
|
[12] |
Isogai T, Yasunaga H, Matsui H, et al. Effectiveness of inferior vena cava filters on mortality as an adjuvant to antithrombotic therapy[J]. Am J Med, 2015, 128(3): 312.e23-31.
|
[13] |
中国医师协会介入医师分会,中华医学会放射学分会介入专业委员会,中国静脉介入联盟. 下腔静脉滤器置入术和取出术规范的专家共识(第2版)[J]. 中华医学杂志, 2020, 100(27): 2092-2101.
|
[14] |
Kaufman JA. Inferior Vena Cava Filters: Current and Future Concepts[J]. Interventional Cardiology Clinics, 2018, 7(1): 129.
|
[15] |
Wang SL, Cha HHA, Lin JR, et al. Impact of physician education and a dedicated inferior vena cava filter tracking system on inferior vena cava filter use and retrieval rates across a large US health care region[J]. Journal of Vascular & Interventional Radiology Jvir, 2016, 27(5): 740-748.
|
[16] |
Lee MJ, Valenti D, de Gregorio MA, et al. The CIRSE retrievable IVC filter registry: retrieval success rates in practice[J]. CardioVascular and Interventional Radiology, 2015, 38(6):1502-1507.
|
[17] |
Kuo WT, Odegaard JI, Rosenberg JK, et al. Laser-assisted removal of embedded vena cava filters: a 5-year first-in-human study[J]. Chest, 2017, 151(2): 417-424.
|
[18] |
Chick JF, Stavropoulos SW, Shin BJ, et al. A 16-F sheath with endobronchial forceps improves reported retrieval success of long-dwelling "closed cell" inferior vena cava filter designs[J]. J Vasc Interv Radiol, 2016, 27: 1027-1033.
|
[19] |
樊刚,李波,董莉. 回收钩贴壁的疑难性下腔静脉滤器取出技巧及应用[J]. 介入放射学杂志, 2015, 24(02): 158-160.
|
[20] |
Nazzal M, El-Fedaly M, Kazan V, et al. Incidence and clinical significance of iliac vein compression[J]. Vascular, 2015, 23(4): 337-343.
|
[21] |
Gagne PJ, Tahara R, Fastaband CP, et al. Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction[J]. J Vasc Surg Venous Lymphat Disord, 2017, 5(5): 678-687.
|
[22] |
Hartung O, Barthelemy P, Arnoux D, et al. Management of pregnancy in women with previous left iliocaval stenting[J]. J Vasc Surg, 2009, 50(2): 355-359.
|
[23] |
O'Sullivan GJ, Sheehan J, Lohan D, et al. Iliofemoral venous stenting extending into the femoral region: Initial clinical experience with the purpose designed Zilva Vena stent[J]. Journal of Cardiovascular Surgery, 2013, 54(2): 255-61.
|
[24] |
O'Sullivan GJ, Mccann-Brown J. Interim results from the prospective study of the Zilver Vena Venous Stent in the treatment of symptomatic iliofemoral venous outflow obstruction in Europe[J]. Journal of Vascular & Interventional Radiology, 2016, 27(3): S140.
|
[25] |
Radaideh Q, Patel NM, Shammas NW. Iliac vein compression:epidemiology,diagnosis and treatment[J]. Vascular Health and Risk Management, 2019, 15: 115-122.
|
[26] |
Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report[J]. Chest, 2016, 149(2): 315-352.
|
[27] |
顾建平,徐克,滕皋军. 下肢深静脉血栓形成介入治疗规范的专家共识(第2版)[J]. 介入放射学杂志, 2019, 28(01): 1-10.
|